medRxiv : the preprint server for health sciences · 2026
Performance and Fairness of a Peripheral Artery Disease Detection Model Across Patient Phenotypes and Health Systems.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kallis Karoline, Quitevis Chyler, Ramsis Mattheus, Kabutey Nii-Kabu, Conte Michael S, Rowe Vincent L, Humphries Misty D, Hernandez-Boussard Tina, Malas Mahmoud B, Ross Elsie G
Аннотация
BACKGROUND: Peripheral artery disease (PAD) is a major cause of cardiovascular events but remains underdiagnosed. Electronic health record (EHR)-based machine learning models show promise for earlier detection, but developing generalizable and fair models across diverse populations remains challenging.
METHODS: Using the University of California Health Data Warehouse, containing EHR data from five health systems, we identified patients with and without PAD. We used unsupervised clustering to define PAD phenotypes and trained a LightGBM classifier using 14,023 features spanning demographics, comorbidities, medications, laboratory values, healthcare utilization, and diagnosis, procedure, and medication codes. We evaluated performance overall and across demographic groups and phenotypes, and assessed fairness using selection rates and subgroup differences in true- and false-positive rates.
RESULTS: The study included 33,739 cases and 33,739 matched controls. Clustering identified four phenotypes: patients with limited healthcare documentation (cluster 1), younger patients with severe metabolic disease (cluster 2), patients with a traditional atherosclerotic risk profile (cluster 3), and frail elderly patients with multimorbidity (cluster 4). Overall, the model demonstrated consistent performance across institutions (AUROC 0.76-0.79; AUC-PR 0.76-0.79) with well- calibrated probabilities. Performance was similar across genders, with modest variation by race and age, and was stronger in clusters 2-4. Cluster 2 demonstrated the highest sensitivity (TPR 0.87, 95% CI 0.87-0.88), while cluster 1 showed the lowest performance (TPR 0.40, 95% CI 0.39-0.41).
CONCLUSIONS: The EHR-based PAD detection model demonstrated consistent performance across five health systems. Phenotypic clustering revealed clinically meaningful differences in model performance adding an additional consideration in ML fairness and performance evaluations.
METHODS: Using the University of California Health Data Warehouse, containing EHR data from five health systems, we identified patients with and without PAD. We used unsupervised clustering to define PAD phenotypes and trained a LightGBM classifier using 14,023 features spanning demographics, comorbidities, medications, laboratory values, healthcare utilization, and diagnosis, procedure, and medication codes. We evaluated performance overall and across demographic groups and phenotypes, and assessed fairness using selection rates and subgroup differences in true- and false-positive rates.
RESULTS: The study included 33,739 cases and 33,739 matched controls. Clustering identified four phenotypes: patients with limited healthcare documentation (cluster 1), younger patients with severe metabolic disease (cluster 2), patients with a traditional atherosclerotic risk profile (cluster 3), and frail elderly patients with multimorbidity (cluster 4). Overall, the model demonstrated consistent performance across institutions (AUROC 0.76-0.79; AUC-PR 0.76-0.79) with well- calibrated probabilities. Performance was similar across genders, with modest variation by race and age, and was stronger in clusters 2-4. Cluster 2 demonstrated the highest sensitivity (TPR 0.87, 95% CI 0.87-0.88), while cluster 1 showed the lowest performance (TPR 0.40, 95% CI 0.39-0.41).
CONCLUSIONS: The EHR-based PAD detection model demonstrated consistent performance across five health systems. Phenotypic clustering revealed clinically meaningful differences in model performance adding an additional consideration in ML fairness and performance evaluations.